WallStSmart
SLGC

Somalogic Inc

NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES

$9.90
+0.00% today

Updated 2026-05-28

Market cap
$396.23M
P/E ratio
P/S ratio
4.85x
EPS (TTM)
$-0.69
Dividend yield
52W range
$19 – $20
Volume
0.0M

Somalogic Inc (SLGC) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20192020202120222023
Operating cash flow$-50.54M$-28.34M$-36.97M$-100.67M$-117.25M
Capital expenditures$680000.00$1.16M$6.73M$5.21M$4.64M
Depreciation
Stock-based comp$13.07M$15.17M$28.41M$43.61M$24.08M
Free cash flow$-51.22M$-29.50M$-43.70M$-105.88M$-121.89M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$275.09M$-12.94M

Frequently asked questions

What is Somalogic Inc's revenue?

Somalogic Inc's trailing twelve-month revenue is $81.72M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is SLGC?

In its most recent fiscal year, SLGC ran a gross margin of 41.15%, an operating margin of -186.64%, and a net margin of -159.54%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does SLGC generate?

SLGC produced $-121.89M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.